CTNM CONTINEUM THERAPEUTICS INC

Ownership history in BAILARD, INC.  ·  1 quarter on record

This page tracks every 13F SEC filing in which BAILARD, INC. reported a position in CONTINEUM THERAPEUTICS INC (CTNM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 12,350 0.00% $145K $11.75
% of Fund (quarterly)    CTNM price (monthly, adj. close)
← Back to BAILARD, INC. Holdings